• レポートコード:PMR20MY020 • 出版社/出版日:Persistence Market Research / 2020年2月7日 • レポート形態:英文、PDF、170ページ • 納品方法:Eメール • 産業分類:健康管理 |
Individual User(1名用) | ¥666,000 (USD4,500) | ▷ お問い合わせ |
Multi User(5名用) | ¥962,000 (USD6,500) | ▷ お問い合わせ |
Corporate User(企業用) | ¥1,258,000 (USD8,500) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の無菌活性医薬品成分市場について調査・分析し、エグゼクティブサマリー、市場概要、市場動向、市場背景、北米、中南米、ヨーロッパ、南アジア、東アジア、オセアニア市場分析及び予測などを含め、以下の構成でお届け致します。 ・世界の無菌活性医薬品成分市場:エグゼクティブサマリー ・世界の無菌活性医薬品成分市場:概要 ・世界の無菌活性医薬品成分市場:動向 ・世界の無菌活性医薬品成分市場:背景 ・北米の無菌活性医薬品成分市場:分析及び予測 ・中南米の無菌活性医薬品成分市場:分析及び予測 ・ヨーロッパの無菌活性医薬品成分市場:分析及び予測 ・南アジアの無菌活性医薬品成分市場:分析及び予測 ・東アジアの無菌活性医薬品成分市場:分析及び予測 ・オセアニアの無菌活性医薬品成分市場:分析及び予測 … |
Sterile Active Pharmaceutical Ingredients Market – Scope of the Report
Fact.MR recently published a market study on the global market for sterile active pharmaceutical ingredients. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the sterile active pharmaceutical ingredients market structure. The market study presents exclusive information about how the sterile active pharmaceutical ingredients market will grow during the forecast period (2019-2029).
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in Fact.MR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the sterile active pharmaceutical ingredients market during the forecast period.
The study is relevant for stakeholders in the sterile active pharmaceutical ingredients market, including sterile active pharmaceutical ingredients manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the sterile active pharmaceutical ingredients market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in Fact.MR’s study.
The study also includes statistics as well as facts related to macro as well as microeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the sterile active pharmaceutical ingredients market. Furthermore, small businesses and new entrants in the sterile active pharmaceutical ingredients market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.
Key Questions Answered in Fact.MR’s Sterile Active Pharmaceutical Ingredients Market Report
Which regions will continue to remain the most profitable regional markets for sterile active pharmaceutical ingredients market players?
Which factors will induce a change in the demand for sterile active pharmaceutical ingredients manufacturers during the assessment period?
How will changing trends impact the sterile active pharmaceutical ingredients market?
How can market players capture the low-hanging opportunities in the sterile active pharmaceutical ingredients market in developed regions?
Which companies are leading the sterile active pharmaceutical ingredients market?
What are the winning strategies of stakeholders in the sterile active pharmaceutical ingredients market to upscale their position in this landscape?
Sterile Active Pharmaceutical Ingredients Market: Research Methodology
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the sterile active pharmaceutical ingredients market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of conclusions.
Secondary resources referred to analysts during the production of the sterile active pharmaceutical ingredients market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the sterile active pharmaceutical ingredients market, and makes Fact.MR’s projection on the growth prospects of the sterile active pharmaceutical ingredients market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Technology Trends
4. Market Background
4.1. Macro-Economic Factors
4.2. Forecast Factors – Relevance & Impact
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
4.4. Parent Market Analysis
5. Global Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014-2018
5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019-2029
5.3.1. Monoclonal Antibody
5.3.2. Immunoglobulin
5.3.3. Cytokines
5.3.4. Insulin
5.3.5. Peptide Hormones
5.3.6. Blood Factors
5.3.7. Peptide Antibiotics
5.3.8. Vaccines
5.3.9. Small Molecule Antibiotics
5.3.10. Highly Potent Active Pharmaceutical Ingredients (HPAPI)
5.3.11. Others
5.4. Market Attractiveness Analysis By Product Type
6. Global Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029, by Form
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Form, 2014-2018
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Form, 2019-2029
6.3.1. Aqueous
6.3.2. Non-aqueous liquid
6.3.3. Dry powder
6.4. Market Attractiveness Analysis By Form
7. Global Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029, by Region
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
7.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2029
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia
7.3.6. Oceania
7.3.7. Middle East and Africa (MEA)
7.4. Market Attractiveness Analysis By Region
8. North America Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
8.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
8.3.1. By Country
8.3.1.1. U.S.
8.3.1.2. Canada
8.3.2. By Product Type
8.3.3. By Form
8.4. Market Attractiveness Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Form
9. Latin America Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
9.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
9.3.1. By Country
9.3.1.1. Brazil
9.3.1.2. Mexico
9.3.1.3. Rest of Latin America
9.3.2. By Product Type
9.3.3. By Form
9.4. Market Attractiveness Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Form
10. Europe Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
10.3.1. By Country
10.3.1.1. Germany
10.3.1.2. Italy
10.3.1.3. France
10.3.1.4. U.K.
10.3.1.5. Spain
10.3.1.6. Russia
10.3.1.7. Rest of Europe
10.3.2. By Product Type
10.3.3. By Form
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Form
11. South Asia Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
11.3.1. By Country
11.3.1.1. India
11.3.1.2. Thailand
11.3.1.3. Indonesia
11.3.1.4. Malaysia
11.3.1.5. Rest of South Asia
11.3.2. By Product Type
11.3.3. By Form
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product Type
11.4.3. By Form
12. East Asia Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
12.3.1. By Country
12.3.1.1. China
12.3.1.2. Japan
12.3.1.3. South Korea
12.3.2. By Product Type
12.3.3. By Form
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product Type
12.4.3. By Form
13. Oceania Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
13.3.1. By Country
13.3.1.1. Australia
13.3.1.2. New Zealand
13.3.2. By Product Type
13.3.3. By Form
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By Form
14. Middle East and Africa Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
14.3.1. By Country
14.3.1.1. GCC Countries
14.3.1.2. Turkey
14.3.1.3. Northern Africa
14.3.1.4. South Africa
14.3.1.5. Rest of Middle East and Africa
14.3.2. By Product Type
14.3.3. By Form
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By Form
15. Emerging Countries Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.1.1. Market Value Proportion Analysis, By Key Countries
15.1.2. Global Vs. Country Growth Comparison
15.2. China Sterile Active Pharmaceutical Ingredients Market Analysis
15.2.1. Introduction
15.2.2. Market Value Proportion Analysis by Market Taxonomy
15.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
15.2.3.1. By Product Type
15.2.3.2. By Form
15.3. Mexico Sterile Active Pharmaceutical Ingredients Market Analysis
15.3.1. Introduction
15.3.2. Market Value Proportion Analysis by Market Taxonomy
15.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
15.3.3.1. By Product Type
15.3.3.2. By Form
15.4. India Sterile Active Pharmaceutical Ingredients Market Analysis
15.4.1. Introduction
15.4.2. Market Value Proportion Analysis by Market Taxonomy
15.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
15.4.3.1. By Product Type
15.4.3.2. By Form
16. Market Structure Analysis
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Deep Dive
17.2.1. Aurobindo Pharma Limited
17.2.1.1. Overview
17.2.1.2. Sterile API Portfolio
17.2.1.3. Key Financials
17.2.1.4. Key Developments
17.2.1.5. Analyst Commentary
17.2.2. Teva Pharmaceutical Industries Ltd.
17.2.2.1. Overview
17.2.2.2. Sterile API Portfolio
17.2.2.3. Key Financials
17.2.2.4. Key Developments
17.2.2.5. Analyst Commentary
17.2.3. Corden Pharma GmbH
17.2.3.1. Overview
17.2.3.2. Sterile API Portfolio
17.2.3.3. Key Financials
17.2.3.4. Key Developments
17.2.3.5. Analyst Commentary
17.2.4. Dalton Pharma Services
17.2.4.1. Overview
17.2.4.2. Sterile API Portfolio
17.2.4.3. Key Financials
17.2.4.4. Key Developments
17.2.4.5. Analyst Commentary
17.2.5. Pfizer Inc.
17.2.5.1. Overview
17.2.5.2. Sterile API Portfolio
17.2.5.3. Key Financials
17.2.5.4. Key Developments
17.2.5.5. Analyst Commentary
17.2.6. Sun Pharmaceutical Industries Ltd.
17.2.6.1. Overview
17.2.6.2. Sterile API Portfolio
17.2.6.3. Key Financials
17.2.6.4. Key Developments
17.2.6.5. Analyst Commentary
17.2.7. Lonza Group
17.2.7.1. Overview
17.2.7.2. Sterile API Portfolio
17.2.7.3. Key Financials
17.2.7.4. Key Developments
17.2.7.5. Analyst Commentary
17.2.8. Albany Molecular Research Inc.
17.2.8.1. Overview
17.2.8.2. Sterile API Portfolio
17.2.8.3. Key Financials
17.2.8.4. Key Developments
17.2.8.5. Analyst Commentary
17.2.9. Sanofi S.A
17.2.9.1. Overview
17.2.9.2. Sterile API Portfolio
17.2.9.3. Key Financials
17.2.9.4. Key Developments
17.2.9.5. Analyst Commentary
17.2.10. Dr. Reddy’s Laboratories Ltd
17.2.10.1. Overview
17.2.10.2. Sterile API Portfolio
17.2.10.3. Key Financials
17.2.10.4. Key Developments
17.2.10.5. Analyst Commentary
18. Assumptions and Acronyms Used
19. Research Methodology
List of TablesTable 01: Global Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029 By Product Type
Table 02: Global Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029 By Form
Table 03: Global Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029 By Region
Table 04: North America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country
Table 05: North America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type
Table 06: North America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form
Table 07: Latin America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country
Table 08: Latin America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type
Table 09: Latin America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form
Table 10: Europe Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country
Table 11: Europe Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type
Table 12: Europe Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form
Table 13: South Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country
Table 14: South Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type
Table 15: South Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form
Table 16: East Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country
Table 17: East Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type
Table 18: East Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form
Table 19: Oceania Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country
Table 20: Oceania Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type
Table 21: Oceania Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form
Table 22: Middle East & Africa Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country
Table 23: Middle East & Africa Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type
Table 24: Middle East & Africa Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form
Table 25: China Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type
Table 26: China Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form
Table 27: Mexico Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type
Table 28: Mexico Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form
Table 29: India Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type
Table 30: India Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form